Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Behav Brain Res ; 190(2): 206-11, 2008 Jul 19.
Artigo em Inglês | MEDLINE | ID: mdl-18395808

RESUMO

Lesion of the nucleus basalis magnocellularis (nbm) is a suitable approach to study cognitive deficit and behavior alterations involving cholinergic dysfunction, which is associated with the major types of dementia. Cortical astrogliosis also has been described in this model, but it is not clear whether hippocampal astrocytes are activated. In this study, we investigated possible specific astrocyte alterations in the hippocampi of Wistar rats submitted to nbm damage with ibotenic acid, investigating the content and immunohistochemistry of glial fibrillary acidic protein (GFAP), as well as S100B protein content, glutamate uptake and glutamine synthetase activity on the 7th and 28th post-lesion days. Cognitive deficit was confirmed by the step-down inhibitory avoidance task. Interestingly, we found a decrease in GFAP content, S100B content and glutamate uptake activity in the hippocampus on the 28th day after nbm lesion. No alterations were observed in glutamine synthetase activity or in the cerebrospinal fluid S100B content. Although our data suggest caution in the use of nbm lesion with ibotenic acid as a dementia model, it is possible that these alterations could contribute to the cognitive deficit observed in these rats.


Assuntos
Astrócitos/citologia , Aprendizagem da Esquiva/fisiologia , Núcleo Basal de Meynert/fisiologia , Fibras Colinérgicas/metabolismo , Demência/fisiopatologia , Hipocampo/citologia , Animais , Astrócitos/metabolismo , Núcleo Basal de Meynert/citologia , Núcleo Basal de Meynert/efeitos dos fármacos , Dano Encefálico Crônico/induzido quimicamente , Contagem de Células , Demência/metabolismo , Modelos Animais de Doenças , Comportamento Exploratório/fisiologia , Seguimentos , Proteína Glial Fibrilar Ácida/metabolismo , Glutamato-Amônia Ligase/metabolismo , Ácido Glutâmico/metabolismo , Habituação Psicofisiológica/fisiologia , Hipocampo/metabolismo , Ácido Ibotênico , Imuno-Histoquímica , Masculino , Fatores de Crescimento Neural/metabolismo , Ratos , Ratos Wistar , Subunidade beta da Proteína Ligante de Cálcio S100 , Proteínas S100/metabolismo , Estatísticas não Paramétricas , Fatores de Tempo
2.
J Psychiatr Res ; 41(6): 523-9, 2007 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16956621

RESUMO

Bipolar disorder (BD) is a chronic, severe, and highly disabling psychiatric disorder; peripheral markers have been used to assess biochemical alterations associated with BD and/or possibly involved in its pathophysiology. Beyond neuronal commitment, many groups have proposed the involvement of glial activity in psychiatric disorders. Other biochemical markers, particularly associated with oxidative stress, have been studied in BD. In the present study, we evaluated glial involvement and oxidative stress in patients with BD. Glial activity was assessed by measuring serum S100B content; oxidative stress was assessed using serum thiobarbituric acid reactive substances (TBARS) and activities of antioxidant enzymes in BD patients during different episodes of disease. We found a significant increment of serum S100B during episodes of mania and depression, but not in euthymic patients. Superoxide dismutase (SOD) activity, as well the SOD/glutathione peroxidase plus catalase ratio, was also increased in manic and depressed patients. On the other hand, TBARS levels were increased in BD patients regardless of the phase of the disorder. These findings suggest a potential oxidative damage in BD patients. This peripheral oxidative imbalance indicates that systemic changes are taking place during the active phases of the illness. Such changes appear to relate to astrocyte function, as indicated by serum S100B elevation.


Assuntos
Antioxidantes/fisiologia , Transtorno Bipolar/sangue , Transtorno Bipolar/fisiopatologia , Catalase/sangue , Glutationa Peroxidase/sangue , Fatores de Crescimento Neural/sangue , Proteínas S100/sangue , Superóxido Dismutase/sangue , Adulto , Estudos de Casos e Controles , Demografia , Ensaio de Imunoadsorção Enzimática , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estresse Oxidativo/fisiologia , Subunidade beta da Proteína Ligante de Cálcio S100 , Espectrofotometria
3.
Neurochem Res ; 30(9): 1101-8, 2005 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16292502

RESUMO

Phosphorylation of the glial fibrillary acidic protein (GFAP) in hippocampal and cerebellar slices from immature rats is stimulated by glutamate. This effect occurs via a group II metabotropic glutamate receptor in the hippocampus and an NMDA ionotropic receptor in the cerebellum. We investigated the glutamate modulation of GFAP phosphorylation in the olfactory bulb slices of Wistar rats of different ages (post-natal day 15 = P15, post-natal day 21 = P21 and post-natal day 60 = P60). Our results showed that glutamate stimulates GFAP phosphorylation in young animals and this is mediated by NMDA receptors. We also observed a decrease in glutamate uptake at P60 compared to P15, a finding similar to that found in the hippocampus. The activity of glutamine synthetase was elevated after birth, but was found to decrease with development from P21 to P60. Together, these data confirm the importance of glutamatergic transmission in the olfactory bulb, its developmental regulation in this brain structure and extends the concept of glial involvement in glutamatergic neuron-glial communication.


Assuntos
Proteína Glial Fibrilar Ácida/metabolismo , Glutamato-Amônia Ligase/metabolismo , Ácido Glutâmico/metabolismo , Bulbo Olfatório , Fatores Etários , Animais , Transporte Biológico , Feminino , Masculino , Bulbo Olfatório/crescimento & desenvolvimento , Bulbo Olfatório/metabolismo , Fosforilação , Ratos , Ratos Wistar
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA